Cel-Sci Corporation Company Profile
NYSE: CVMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cel-Sci at a glance
Cel-Sci Corporation (NYSE: CVM) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Vienna, VA. Cel-Sci is led by Mr. Geert R. Kersten Esq.. The company's shares have traded publicly since 1997.
At a market capitalization of $21.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0000725363, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Cel-Sci do?
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
Business description based on the company's public filings.
Company information
- Legal name
- Cel-Sci Corporation
- Ticker
- NYSE: CVM
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Mr. Geert R. Kersten Esq.
- Headquarters
- 8229 Boone Boulevard, Vienna, VA, United States
- Phone
- 703 506 9460
- Website
- cel-sci.com
- IPO year
- 1997
- Market cap
- $21.28M
- SEC CIK
- 0000725363
- Latest annual report
- 10-K · Dec 29, 2025
Companies similar to Cel-Sci
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MGXMetagenomi Therapeutics Inc. | 0.565 | -7.95% | $21.36M | vs CVM |
| EVAXEvaxion A/S ADR | 2.25 | +10.84% | $20.75M | vs CVM |
| SAENGenenta Science S.p.A. ADR | 0.5074 | -9.39% | $24.47M | vs CVM |
| PTHSPelthos Therapeutics Inc. | 6.38 | -8.73% | $25.08M | vs CVM |
| INMBINmune Bio Inc. | 0.827 | -7.50% | $25.60M | vs CVM |
| LONALeonaBio Inc. | 2.02 | -17.89% | $26.41M | vs CVM |
| EXOZeXoZymes Inc. | 2.91 | -14.05% | $27.42M | vs CVM |
| ESLAEstrella Immunopharma Inc. | 0.321 | -5.70% | $14.11M | vs CVM |